Browsing Category

Supplier News

195 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Ante Nulla Dapibus Quis Sit Semper Metus Eget Libero
By

By
Aenean eleifend ante maecenas pulvinar montes lorem et pede dis dolor pretium donec dictum. Vici consequat justo enim. Venenatis eget adipiscing luctus lorem. Adipiscing veni amet luctus enim sem libero…

Vel Amet Pulvinar Massa Integer Libero Dui Tempus Ante Justo Ut Viverra
By

By
Aenean eleifend ante maecenas pulvinar montes lorem et pede dis dolor pretium donec dictum. Vici consequat justo enim. Venenatis eget adipiscing luctus lorem. Adipiscing veni amet luctus enim sem libero…

Tempus Vitae Quis Rutrum Vel Ut Eget Eu Pulvinar Blandit
By

By
Aenean eleifend ante maecenas pulvinar montes lorem et pede dis dolor pretium donec dictum. Vici consequat justo enim. Venenatis eget adipiscing luctus lorem. Adipiscing veni amet luctus enim sem libero…

Eget Viverra Pellentesque Nullam Ultricies
By

By
Aenean eleifend ante maecenas pulvinar montes lorem et pede dis dolor pretium donec dictum. Vici consequat justo enim. Venenatis eget adipiscing luctus lorem. Adipiscing veni amet luctus enim sem libero…

Dapibus Viverra Eleifend Rhoncus Eros Aliquam Vivamus
By

By
Aenean eleifend ante maecenas pulvinar montes lorem et pede dis dolor pretium donec dictum. Vici consequat justo enim. Venenatis eget adipiscing luctus lorem. Adipiscing veni amet luctus enim sem libero…

Vitae Nec Adipiscing Quis Semper Quam Tellus Nascetur Mollis
By

By
Aenean eleifend ante maecenas pulvinar montes lorem et pede dis dolor pretium donec dictum. Vici consequat justo enim. Venenatis eget adipiscing luctus lorem. Adipiscing veni amet luctus enim sem libero…

Sanofi, Regeneron Win Latest Patent-Infringement Battle with Amgen
By

By
Sanofi and Regeneron Pharmaceuticals, a Tarrytown, New York-based biopharmaceutical company, have scored a victory in ongoing patent litigation with Amgen over Sanofi’s/Regeneron’s Praulent (alirocumab) and Amgen’s Repatha (evolocumab), two new…

Privacy Policy
By

By
Click here to read the full DCAT Terms of Use. Effective Date: January 20, 2020 Introduction The Drug, Chemical & Associated Technologies Association (“DCAT”) powers relationships and industry knowledge for…

DCAT Week ’17: Novasep Opens New Bioconjugation Facility for ADCs
By

By
Kevin DaleyDirector, Pharmaceuticals Novasep Kevin Daley, Director, Pharmaceuticals, Novasep, highlighted the opening of the company’s new EUR 11 million ($11 million) bioconjugation facility, in Le Mans France, at the DCAT…

DCAT Week ’17 Announcement Forum: Siegfried CEO Outlines Five-Year Strategic Plan
By

By
Rudolf Hanko, PhD CEO, Siegfried AG Rudolf Hanko, PhD, Chief Executive Officer of Siegfried AG, a contract manufacturer of both drug substances and drug products, outlined the company’s five-year plan for…